Mitochondrial dysfunction and coenzyme Q10 supplementation in post-viral fatigue syndrome: an overview
D Mantle, IP Hargreaves, JC Domingo… - International Journal of …, 2024 - mdpi.com
Post-viral fatigue syndrome (PVFS) encompasses a wide range of complex neuroimmune
disorders of unknown causes characterised by disabling post-exertional fatigue, myalgia …
disorders of unknown causes characterised by disabling post-exertional fatigue, myalgia …
Prognosis of patients with long COVID symptoms: a protocol for a longitudinal cohort study at a primary care referred outpatient clinic in Helsinki, Finland
H Virrantaus, H Liira, T Posharina, A Sulg, T Mäntylä… - BMJ open, 2023 - bmjopen.bmj.com
Introduction After COVID-19, many continue to experience persistent debilitating symptoms,
that is, long COVID. Its most prevalent symptoms are chest pain, difficulties with breathing …
that is, long COVID. Its most prevalent symptoms are chest pain, difficulties with breathing …
Evolution of Humoral and Cellular Immunity Post–Breakthrough Coronavirus Disease 2019 in Vaccinated Patients With Hematologic Malignancy Receiving …
VG Hall, THO Nguyen, LF Allen… - Open Forum …, 2023 - academic.oup.com
Background In-depth immunogenicity studies of tixagevimab-cilgavimab (TC) are lacking,
including following breakthrough coronavirus disease 2019 (COVID-19) in vaccinated …
including following breakthrough coronavirus disease 2019 (COVID-19) in vaccinated …
Endemic does not mean constant as SARS-CoV-2 continues to evolve
COVID-19 has become endemic, with dynamics that reflect the waning of immunity and re-
exposure, by contrast to the epidemic phase driven by exposure in immunologically naïve …
exposure, by contrast to the epidemic phase driven by exposure in immunologically naïve …
Clinical features and outcomes in adults with COVID-19 during the pre-Omicron and Omicron waves
M Martinot, A Schieber, JC Ongagna, A Henric… - Infectious Diseases …, 2024 - Elsevier
Objectives We conducted a single-center retrospective study to compare patient
characteristics and death rates during the Omicron (O, December 01, 2021, to September …
characteristics and death rates during the Omicron (O, December 01, 2021, to September …
The Course of COVID-19 and Long COVID: Identifying Risk Factors among Patients Suffering from the Disease before and during the Omicron-Dominant Period
M Babicki, D Kołat, Ż Kałuzińska-Kołat, J Kapusta… - Pathogens, 2024 - mdpi.com
SARS-CoV-2 has acquired many mutations that influence the severity of COVID-19's course
or the risk of developing long COVID. In 2022, the dominant SARS-CoV-2 variant was …
or the risk of developing long COVID. In 2022, the dominant SARS-CoV-2 variant was …
Longitudinal Analysis of Humoral and Cellular Immune Response up to 6 Months after SARS-CoV-2 BA. 5/BF. 7/XBB Breakthrough Infection and BA. 5/BF. 7-XBB …
X Wang, M Zhang, K Wei, C Li, J Yang, S Jiang, C Zhao… - Vaccines, 2024 - mdpi.com
The rapid mutation of SARS-CoV-2 has led to multiple rounds of large-scale breakthrough
infection and reinfection worldwide. However, the dynamic changes of humoral and cellular …
infection and reinfection worldwide. However, the dynamic changes of humoral and cellular …
[HTML][HTML] Vaccinated COVID-19 Index Cases Are Less Likely to Transmit SARS-CoV-2 to Their Household Contacts: A Cohort Study
P Godoy, I Martínez-Baz, I Parron, M García-Cenoz… - Vaccines, 2024 - mdpi.com
The aim of this study was to evaluate the impact of index case vaccination on SARS-CoV-2
transmission to household contacts. In our epidemiological cohort study (May 2022 …
transmission to household contacts. In our epidemiological cohort study (May 2022 …
[HTML][HTML] Risk of SARS-CoV-2 Reinfection 3 Years after the Start of the Pandemic: A Population-Level Observational Study
The risk of SARS-CoV-2 reinfections changes as new variants emerge, but the follow-up
time for most of the available evidence is shorter than two years. This study evaluated SARS …
time for most of the available evidence is shorter than two years. This study evaluated SARS …
[HTML][HTML] Real-World Study: Hybrid Immunity against SARS-CoV-2 Influences the Antibody Levels and Persistency Lasting More than One Year
S Kanokudom, J Chansaenroj, S Assawakosri… - Vaccines, 2023 - mdpi.com
This study investigated the impact of hybrid immunity on antibody responses in the
participants who received two to seven doses of the COVID-19 vaccine. The study was …
participants who received two to seven doses of the COVID-19 vaccine. The study was …